EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, March 19, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ: EPIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 12, 2023 and October 31, 2024, inclusive (the "Class Period"), a ...